Welcome to LookChem.com Sign In|Join Free
  • or
methyl 2-(tert-butoxycarbonylamino)-3,3-diphenylpropanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

177583-36-7

Post Buying Request

177583-36-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

177583-36-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 177583-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,5,8 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 177583-36:
(8*1)+(7*7)+(6*7)+(5*5)+(4*8)+(3*3)+(2*3)+(1*6)=177
177 % 10 = 7
So 177583-36-7 is a valid CAS Registry Number.

177583-36-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-(tert-butoxycarbonylamino)-3,3-diphenylpropanoate

1.2 Other means of identification

Product number -
Other names 2-(N-Boc-amino)-3,3-diphenylpropionic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:177583-36-7 SDS

177583-36-7Relevant academic research and scientific papers

Electrochemical reduction of dehydroamino acids: Synthesis and photophysical properties of β,β-diarylalanines

Ferreira, Paula M.T.,Monteiro, Luís S.,Castanheira, Elisabete M.S.,Pereira, Goreti,Lopes, Carla,Vilaa, Helena

experimental part, p. 193 - 200 (2011/02/27)

Several β,β-disubstituted dehydroalanines were prepared from β,β-dibromo or β-bromo, β-substituted dehydroalanines and aryl boronic acids using a Suzuki-Miyaura cross-coupling reaction. The electrochemical behaviour of these compounds was studied by cyclic voltammetry. All compounds studied showed similar reduction potentials and these were similar to the peak potential of the methyl ester of N-tert-butoxycarbonyl dehydrophenylalanine. Thus, the presence of a second aryl moiety in the dehydroalanine scaffold does not significantly change the reduction potential. Controlled potential electrolyses were performed at the cathodic peak potential in the presence of triethylammonium chloride as proton donor. The only products isolated in good to high yields were the corresponding β,β- diarylalanines. This reaction was also carried out using a dipeptide containing a β,β-diaryldehydroalanine to give a 1:1 diastereomeric mixture of the reduction product. The photophysical properties of two of the β,β-diaryldehydroalanines and of the corresponding β,β-diarylalanines were studied in three solvents of different polarity. The β,β-diaryldehydroalanines show low fluorescent quantum yields (ΦF9%) due to the conjugation of the aromatic moieties with the α,β-double bond and with the carbonyl group, which favours the non-radiative deactivation pathways. The absence of conjugation in the reduction products leads to a significant increase in the fluorescence quantum yields. These results show that the β,β-disubstituted alanines could be used as fluorescent markers.

NOVEL IMIDAZOLIDINONE DERIVATIVE, METHOD OF PRODUCING THE SAME AND METHOD OF PRODUCING OPTICALLY ACTIVE AMINO ACID

-

Page/Page column 40, (2009/05/29)

The objective of the present invention is to provide an optically active imidazolidinone derivative widely usable for synthesizing an optically active amino acid, a method of easily producing the derivative, and a method of easily producing an optically active amino acid by using the derivative. The objective can be achieved by producing an optically active amino acid using a novel optically active imidazolidinone derivative represented by a general formula (3) and the like. According to the method of the present invention, an optically active imidazolidinone derivative can be obtained by preferential crystallization from a mixture of isomers of the imidazolidinone derivative. Therefore, an optically active amino acid can be easily and stereoselectively produced without cumbersome procedures required for the conventional methods, such as resolution of diastereomers, synthesis from an optically active amino acid and resolution of isomers by silica gel column cromatography.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 177583-36-7